Citation Impact
Citing Papers
Dectin-1 Y238X polymorphism associates with susceptibility to invasive aspergillosis in hematopoietic transplantation through impairment of both recipient- and donor-dependent mechanisms of antifungal immunity
2010
Disability in depression and back pain
2003
Prediction of Pulmonary Complications and Long‐Term Survival in Systemic Sclerosis
2014
A Belgian consensus on the definition of a treat‐to‐target outcome set in psoriasis management
2019
Efficacy of conventional synthetic disease-modifying antirheumatic drugs, glucocorticoids and tofacitinib: a systematic literature review informing the 2013 update of the EULAR recommendations for management of rheumatoid arthritis
2014
Plasma Hsp90 levels in patients with systemic sclerosis and relation to lung and skin involvement: a cross-sectional and longitudinal study
2021 Standout
Evidence-based detection of pulmonary arterial hypertension in systemic sclerosis: the DETECT study
2013
Which subgroup of patients with rheumatoid arthritis benefits from switching to rituximab versus alternative anti-tumour necrosis factor (TNF) agents after previous failure of an anti-TNF agent?
2009
Comparison of tocilizumab monotherapy versus methotrexate monotherapy in patients with moderate to severe rheumatoid arthritis: the AMBITION study
2009
Delayed Clinical Response in Patients with Juvenile Idiopathic Arthritis Treated with Etanercept
2010
An Observational Study of Gout Prevalence and Quality of Care in a National Australian General Practice Population
2015
Decline in rheumatoid vasculitis prevalence among US veterans: A retrospective cross‐sectional study
2009
Anti-vascular endothelial growth factor for diabetic macular oedema
2014
Drug-free remission, functioning and radiographic damage after 4 years of response-driven treatment in patients with recent-onset rheumatoid arthritis
2008
Aflibercept, Bevacizumab, or Ranibizumab for Diabetic Macular Edema
2015 Standout
The role of B cells in atherosclerosis
2018
Rheumatoid arthritis
2016 Standout
Abatacept for Rheumatoid Arthritis Refractory to Tumor Necrosis Factor α Inhibition
2005
Prevalence and incidence of systemic sclerosis in southern Sweden: population-based data with case ascertainment using the 1980 ARA criteria and the proposed ACR-EULAR classification criteria
2013
Undiagnosed connective tissue diseases
2016
Toward a Personalized Medicine Approach to the Management of Inflammatory Bowel Disease
2014
Weight loss for overweight and obese individuals with gout: a systematic review of longitudinal studies
2017
Defining remission in rheumatoid arthritis: Results of an initial american college of rheumatology/european league against rheumatism consensus conference
2009
Incidences and Risk Factors of Organ Manifestations in the Early Course of Systemic Sclerosis: A Longitudinal EUSTAR Study
2016
Role of interleukin‐6 in stress, sleep, and fatigue
2012
Current risk factors for work disability associated with rheumatoid arthritis: Recent data from a US national cohort
2009
Impact of Hallmark Autoantibody Reactivity on Early Diagnosis in Scleroderma
2012
Association of concomitant fibromyalgia with worse disease activity score in 28 joints, health assessment questionnaire, and short form 36 scores in patients with rheumatoid arthritis
2009
Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide
2014 Standout
Effectiveness of the primary therapist model for rheumatoid arthritis rehabilitation: A randomized controlled trial
2006
Effectiveness of Nonpharmacological and Nonsurgical Interventions for Patients With Rheumatoid Arthritis: An Overview of Systematic Reviews
2007
Psoriasis treat to target: defining outcomes in psoriasis using data from a real‐world, population‐based cohort study (the British Association of Dermatologists Biologics and Immunomodulators Register, BADBIR )
2019
Optimisation of a treat-to-target approach in rheumatoid arthritis: strategies for the 3-month time point
2015
Digital ulcers predict a worse disease course in patients with systemic sclerosis
2015
SPIRIT 2013 explanation and elaboration: guidance for protocols of clinical trials
2013 Standout
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015: elaboration and explanation
2015 Standout
Adalimumab alone and in combination with disease-modifying antirheumatic drugs for the treatment of rheumatoid arthritis in clinical practice: the Research in Active Rheumatoid Arthritis (ReAct) trial
2007
Trial of Tocilizumab in Giant-Cell Arteritis
2017 Standout
Twenty-two points to consider for clinical trials in systemic sclerosis, based on EULAR standards
2014
Non-specific low back pain
2016 Standout
The Prevalence and Correlates of Adult ADHD in the United States: Results From the National Comorbidity Survey Replication
2006 Standout
Combination therapy with sulfasalazine and methotrexate is more effective than either drug alone in patients with rheumatoid arthritis with a suboptimal response to sulfasalazine: results from the double-blind placebo-controlled MASCOT study
2006
B cell depletion may be more effective than switching to an alternative anti–tumor necrosis factor agent in rheumatoid arthritis patients with inadequate response to anti–tumor necrosis factor agents
2007
EULAR recommendations for the management of early arthritis: report of a task force of the European Standing Committee for International Clinical Studies Including Therapeutics (ESCISIT)
2006
Systemic sclerosis
2017 Standout
The changing landscape of atherosclerosis
2021 StandoutNature
2009 Focused Update Incorporated Into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults
2009 Standout
The differential diagnosis of systemic sclerosis
2013
Immunogenic cell death in cancer and infectious disease
2016 Standout
The Risk of Infections with Biologic Therapies for Rheumatoid Arthritis
2009
Evidence for oesophageal and anorectal involvement in very early systemic sclerosis (VEDOSS): report from a single VEDOSS/EUSTAR centre
2013
Central sensitization: Implications for the diagnosis and treatment of pain
2010 Standout
Psoriasis
2021 Standout
Noninvasive Treatments for Acute, Subacute, and Chronic Low Back Pain: A Clinical Practice Guideline From the American College of Physicians
2017 Standout
Colorectal cancer
2013 Standout
Performance of the new ACR/EULAR classification criteria for systemic sclerosis in clinical practice
2015
Diagnostic accuracy of ultrasound in patients with gout: A meta-analysis
2017
Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab
2007
Sustained response to long-term biologics and switching in psoriatic arthritis: results from real life experience
2007
IL-6 as a keystone cytokine in health and disease
2015 Standout
Increased Risk of Recurrent Gout Attacks with Hospitalization
2013
Superiority of SDAI over DAS-28 in assessment of remission in rheumatoid arthritis patients using power Doppler ultrasonography as a gold standard
2010
Clinical management of psoriatic arthritis
2018
Incorporating the Treat-to-Target Concept in Rheumatoid Arthritis
2012
Sex and gender: modifiers of health, disease, and medicine
2020 Standout
Dermatological complications and safety of anti-TNF treatments
2009
The immune system in atherosclerosis
2011 Standout
Graves' Ophthalmopathy
2010 Standout
Comparison of the response to infliximab or etanercept monotherapy with the response to cotherapy with methotrexate or another disease‐modifying antirheumatic drug in patients with rheumatoid arthritis: Results from the British Society for Rheumatology Biologics Register
2006
Crohn's disease
2016 Standout
RAPID3 (Routine Assessment of Patient Index Data 3), a Rheumatoid Arthritis Index Without Formal Joint Counts for Routine Care: Proposed Severity Categories Compared to Disease Activity Score and Clinical Disease Activity Index Categories
2008
Gout
2016 Standout
Safety and Efficacy of the Selective Costimulation Modulator Abatacept in Patients with Rheumatoid Arthritis Receiving Background Methotrexate: A 5-year Extended Phase IIB Study
2009
Anakinra for Rheumatoid Arthritis: A Systematic Review
2009
Efficacy and safety of abatacept or infliximab vs placebo in ATTEST: a phase III, multi-centre, randomised, double-blind, placebo-controlled study in patients with rheumatoid arthritis and an inadequate response to methotrexate
2007
Updated consensus statement on biological agents for the treatment of rheumatic diseases, 2010
2011 Standout
Tight control in the treatment of rheumatoid arthritis: efficacy and feasibility
2007
Non-pharmacological care for patients with generalized osteoarthritis: design of a randomized clinical trial
2010
Results of a two‐year followup study of patients with rheumatoid arthritis who received a combination of abatacept and methotrexate
2008
Diagnostic accuracy of dual-energy computed tomography in patients with gout: A meta-analysis
2017
Prevalence of type 2 diabetes and impaired fasting glucose in patients affected by rheumatoid arthritis
2017
European biologicals registers: methodology, selected results and perspectives
2008
The PREMIER study: A multicenter, randomized, double‐blind clinical trial of combination therapy with adalimumab plus methotrexate versus methotrexate alone or adalimumab alone in patients with early, aggressive rheumatoid arthritis who had not had previous methotrexate treatment
2005
Preferred reporting items for systematic review and meta-analysis protocols (PRISMA-P) 2015 statement
2015 Standout
Sex and inflammation in respiratory diseases: a clinical viewpoint
2013
Efficacy and safety of the selective co-stimulation modulator abatacept following 2 years of treatment in patients with rheumatoid arthritis and an inadequate response to anti-tumour necrosis factor therapy
2007
Rheumatoid arthritis
2010 Standout
Rheumatoid arthritis: pathological mechanisms and modern pharmacologic therapies
2018
Analysis of SF and plasma cytokines provides insights into the mechanisms of inflammatory arthritis and may predict response to therapy
2011
Functional Specialization of Interleukin-17 Family Members
2011 Standout
Poor clinical response in rheumatoid arthritis is the main risk factor for diabetes development in the short-term: A 1-year, single-centre, longitudinal study
2017
Evidence for treating rheumatoid arthritis to target: results of a systematic literature search
2010
Serious bacterial infections in patients with rheumatoid arthritis under anti-TNF-alpha therapy
2003
Serum Interleukin 6 Is Predictive of Early Functional Decline and Mortality in Interstitial Lung Disease Associated with Systemic Sclerosis
2013
Evidence for treating rheumatoid arthritis to target: results of a systematic literature search update
2015
Evidence-Based Interventions to Improve the Palliative Care of Pain, Dyspnea, and Depression at the End of Life: A Clinical Practice Guideline from the American College of Physicians
2008
The comparative effectiveness of anti-TNF therapy and methotrexate in patients with psoriatic arthritis: 6 month results from a longitudinal, observational, multicentre study
2007
Cancer cachexia: A systematic literature review of items and domains associated with involuntary weight loss in cancer
2011
Abatacept for Rheumatoid Arthritis: A Cochrane Systematic Review
2010
Treatment recommendations for psoriatic arthritis
2008
Efficacy and tolerability of anti-tumour necrosis factor therapy in psoriatic arthritis patients: results from the South Swedish Arthritis Treatment Group register
2007
Cost‐utility analysis of treatment strategies in patients with recent‐onset rheumatoid arthritis
2009
The immunopathology of sepsis and potential therapeutic targets
2017 Standout
Evaluating drug-free remission with abatacept in early rheumatoid arthritis: results from the phase 3b, multicentre, randomised, active-controlled AVERT study of 24 months, with a 12-month, double-blind treatment period
2014
Cytokines in the pathogenesis of rheumatoid arthritis
2007 Standout
Serum Levels of Calreticulin in Correlation with Disease Activity in Patients with Rheumatoid Arthritis
2013
Immunity to fungal infections
2011 Standout
Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial
2008
Cost-effectiveness of abatacept, rituximab, and TNFi treatment after previous failure with TNFi treatment in rheumatoid arthritis: a pragmatic multi-centre randomised trial
2015
Self-management of rheumatic diseases: state of the art and future perspectives
2010
Systemic sclerosis
2015
Anti-TNF Antibody Therapy in Rheumatoid Arthritis and the Risk of Serious Infections and Malignancies
2006 Standout
Performance of the 2011 ACR/EULAR preliminary remission criteria compared with DAS28 remission in unselected patients with rheumatoid arthritis
2012
Inflammation in obesity, diabetes, and related disorders
2022 Standout
The course of established rheumatoid arthritis
2007
Longterm Safety and Efficacy of Tocilizumab in Patients with Rheumatoid Arthritis: A Cumulative Analysis of Up to 4.6 Years of Exposure
2013
Interleukin-6 inhibition for treatment of rheumatoid arthritis: A review of tocilizumab therapy
2010
Is DAS28 an appropriate tool to assess remission in rheumatoid arthritis?
2005
Potential of nintedanib in treatment of progressive fibrosing interstitial lung diseases
2019
Nrf2 activation improves experimental rheumatoid arthritis
2023 StandoutNobel
Self-management education programmes for osteoarthritis
2014 Standout
Extending the CONSORT Statement to Randomized Trials of Nonpharmacologic Treatment: Explanation and Elaboration
2008 Standout
Short‐Term Pulmonary Function Trends Are Predictive of Mortality in Interstitial Lung Disease Associated With Systemic Sclerosis
2017
Nintedanib for Systemic Sclerosis–Associated Interstitial Lung Disease
2019 Standout
Derivation and External Validation of a Prediction Rule for Five‐Year Mortality in Patients With Early Diffuse Cutaneous Systemic Sclerosis
2015
Borderline pulmonary arterial pressure in systemic sclerosis patients: a post-hoc analysis of the DETECT study
2014
Application of a Novel Diagnostic Rule in the Differential Diagnosis between Acute Gouty Arthritis and Septic Arthritis
2015
Exercise interventions on health-related quality of life for cancer survivors
2012
Receiver-operating characteristic (ROC) plots: a fundamental evaluation tool in clinical medicine
1993 Standout
Evidence for Improving Palliative Care at the End of Life: A Systematic Review
2008
The Prevalence and Correlates of Adult ADHD in the United States: Results From the National Comorbidity Survey Replication
2006 Standout
Risk of Serious Infection With Biologic and Systemic Treatment of Psoriasis
2015
Oral Prednisolone in the Treatment of Acute Gout
2016
Derivation and Validation of a Prediction Rule for Two‐Year Mortality in Early Diffuse Cutaneous Systemic Sclerosis
2014
Effects of Abatacept in Patients with Methotrexate-Resistant Active Rheumatoid Arthritis
2006
Efficacy of tocilizumab and evaluation of clinical remission as determined by CDAI and MMP-3 level
2009
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
2019 Standout
Gout
2021 Standout
mice: Multivariate Imputation by Chained Equations inR
2011 Standout
Cancer Cachexia in the Age of Obesity: Skeletal Muscle Depletion Is a Powerful Prognostic Factor, Independent of Body Mass Index
2013 Standout
IL-1 inhibition improves insulin resistance and adipokines in rheumatoid arthritis patients with comorbid type 2 diabetes
2019
Vagus nerve stimulation inhibits cytokine production and attenuates disease severity in rheumatoid arthritis
2016
Disease activity measures for rheumatoid arthritis.
2008
Multidisciplinary biopsychosocial rehabilitation for chronic low back pain
2014
Mortality in rheumatoid arthritis: 2008 update.
2009
Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: a systematic review and economic evaluation
2008
Osteoarthritis: an update with relevance for clinical practice
2011 Standout
Does weight loss reduce the severity and incidence of psoriasis or psoriatic arthritis? A Critically Appraised Topic
2019
Efficacy and safety of infliximab vs. methotrexate in patients with moderate-to-severe plaque psoriasis: results of an open-label, active-controlled, randomized trial (RESTORE1)
2011
Impaired T cell receptor signaling and development of T cell–mediated autoimmune arthritis
2020 StandoutNobel
Interventions for preventing falls in older people living in the community
2012 Standout
Low-Dose Prednisone Inclusion in a Methotrexate-Based, Tight Control Strategy for Early Rheumatoid Arthritis
2012
Pathophysiology, Clinical Presentation, and Treatment of Psoriasis
2020 Standout
SPIRIT 2013 Statement: Defining Standard Protocol Items for Clinical Trials
2013 Standout
The likelihood ratio. An improved measure for reporting and evaluating diagnostic test results.
1986
Effects of exercise and nutrition on postural balance and risk of falling in elderly people with decreased bone mineral density: randomized controlled trial pilot study
2007
A New Way of Thinking about Systemic Sclerosis: The Opportunity for a Very Early Diagnosis.
2016
Works of Jaap Fransen being referenced
The validation of a diagnostic rule for gout without joint fluid analysis: a prospective study
2014
Treating to the target of remission in early rheumatoid arthritis is cost-effective: results of the DREAM registry
2013
Circulating levels of the chemokine CCL18 but not CXCL16 are elevated and correlate with disease activity in rheumatoid arthritis
2007
The Disease Activity Score and the EULAR Response Criteria
2009
Methotrexate therapy in rheumatoid arthritis after failure to sulphasalazine: to switch or to add?
2009
Functional consequences of DECTIN-1early stop codon polymorphism Y238X in rheumatoid arthritis
2010
Evaluating guidelines on continuation of anti-tumour necrosis factor treatment after 3 months: clinical effectiveness and costs of observed care and different alternative strategies
2008
The ICIDH-2 as a framework for the assessment of functioning and disability in rheumatoid arthritis
2002
Influence of age and gender on the 28-joint Disease Activity Score (DAS28) in rheumatoid arthritis
2007
Rheumatoid Arthritis Disadvantages Younger Patients for Cardiovascular Diseases: A Meta-Analysis
2016
Clinical prediction of 5-year survival in systemic sclerosis: validation of a simple prognostic model in EUSTAR centres
2011
The evidence provided by a single trial is less reliable than its statistical analysis suggests
2009
Fatigue in knee and hip osteoarthritis: the role of pain and physical function
2011
Preliminary criteria for the very early diagnosis of systemic sclerosis: results of a Delphi Consensus Study from EULAR Scleroderma Trials and Research Group
2010
A simple sample size formula for analysis of covariance in randomized clinical trials
2007
Performance of response criteria for assessing peripheral arthritis in patients with psoriatic arthritis: analysis of data from randomised controlled trials of two tumour necrosis factor inhibitors
2006
Isometric strength measurement for muscle weakness in cancer patients
2002
Influence of guideline adherence on outcome in a randomised controlled trial on the efficacy of methotrexate with folate supplementation in rheumatoid arthritis
2004
Clinical quality management in rheumatoid arthritis: putting theory into practice
2000
Arthritis of the first metatarsophalangeal joint is not always gout: A prospective cohort study in primary care patients
2014
Excess mortality emerges after 10 years in an inception cohort of early rheumatoid arthritis
2010
New classification criteria for gout: a framework for progress
2013
Feasibility and validity of the RADAI, a self‐administered rheumatoid arthritis disease activity index
2000
Remission in rheumatoid arthritis: agreement of the disease activity score (DAS28) with the ARA preliminary remission criteria
2004
Survival and organ involvement in patients with limited cutaneous systemic sclerosis and anti-topoisomerase-I antibodies: determined by skin subtype or auto-antibody subtype? A long-term follow-up study
2016
Development of quality indicators for monitoring of the disease course in rheumatoid arthritis
2009
Preliminary analysis of the Very Early Diagnosis of Systemic Sclerosis (VEDOSS) EUSTAR multicentre study: evidence for puffy fingers as a pivotal sign for suspicion of systemic sclerosis
2013
Difference in the risk of serious infections in patients with rheumatoid arthritis treated with adalimumab, infliximab and etanercept: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry
2012
The effect of disease duration and disease activity on the risk of cardiovascular disease in rheumatoid arthritis patients
2014
Gap between short‐ and long‐term effects of patient education in rheumatoid arthritis patients: A systematic review
2004
Disease activity as a risk factor for myocardial infarction in rheumatoid arthritis
2008
Persistent severe fatigue in patients with rheumatoid arthritis
2007
The prevalence of clinical remission in RA patients treated with anti-TNF: results from the Dutch Rheumatoid Arthritis Monitoring (DREAM) registry
2012
Effectiveness of systematic monitoring of rheumatoid arthritis disease activity in daily practice: a multicentre, cluster randomised controlled trial
2005
Defining minimal disease activity in psoriatic arthritis: a proposed objective target for treatment
2009
Validation of potential classification criteria for systemic sclerosis
2011
Imaging modalities for the classification of gout: systematic literature review and meta-analysis
2014
Is the disease course of rheumatoid arthritis becoming milder?: Time trends since 1985 in an inception cohort of early rheumatoid arthritis
2005
Low disease activity (DAS28≤3.2) reduces the risk of first cardiovascular event in rheumatoid arthritis: a time-dependent Cox regression analysis in a large cohort study
2017
Meta-analysis of tight control strategies in rheumatoid arthritis: protocolized treatment has additional value with respect to the clinical outcome
2010
Anticyclic Citrullinated Peptide Antibodies and Rheumatoid Factor as Risk Factors for 10-year Cardiovascular Morbidity in Patients with Rheumatoid Arthritis: A Large Inception Cohort Study
2017
A tight control treatment strategy aiming for remission in early rheumatoid arthritis is more effective than usual care treatment in daily clinical practice: a study of two cohorts in the Dutch Rheumatoid Arthritis Monitoring registry
2011
The efficacy of anti-TNF in rheumatoid arthritis, a comparison between randomised controlled trials and clinical practice
2007
Feasibility and results of a randomised pilot-study of a work rehabilitation programme
2005
DAS remission cut points.
2007
Rheumatoid arthritis measures: Disease Activity Score (DAS), Disease Activity Score-28 (DAS28), Rapid Assessment of Disease Activity in Rheumatology (RADAR), and Rheumatoid Arthritis Disease Activity Index (RADAI)
2003
Physical Exercise in Cancer Patients During and After Medical Treatment: A Systematic Review of Randomized and Controlled Clinical Trials
2005
Current Use of Health Status Instruments in Randomised Controlled Trials on Patients with Rheumatoid Arthritis
1998
Risk factors for surgical site infections and other complications in elective surgery in patients with rheumatoid arthritis with special attention for anti-tumor necrosis factor: a large retrospective study.
2007
Klinisches Qualitätsmanagement bei der Rheumatoiden Arthritis
2001
\nThe Disease Activity Score and the EULAR response criteria.
2009